Search Results

1 - 10 of 189 items :

  • "Hepatitis C virus" x
Clear All
Investigation of Hepatitis C Virus Infection Rate of Patients in a General Hospital

, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349(9055): 825-832. 7 Robinson JL, Doucette K. The natural history of hepatitis C virus infection acquired during childhood. Liver Int 2012; 32:258-270. 8 Massard J, Ratziu V, Thabut D, Moussalli J, Lebray P, Benhamou Y, et al. Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol 2006;44:19-24. 9 EASL Clinical Practice Guidelines: Management of hepatitis C virus infection. European Association for the Study of the Liver. J Hepatol 2011; 55(2): 245

Open access
Editorial. The Role of Autophagy in Hepatitis C Virus Infection

viral countermeasures. Biochim Biophys 2009;1793:1478-1484. 6 Feldstein A, Kleiner D, Kravetz D, Buck M. Severe hepatocellular injury with apoptosis induced by a hepatitis C polymerase inhibitor. J Clin Gastroenterol 2009;43:374-381. 7 Dreux M, Chisari FV. Impact of the autophagy machinery on hepatitis C virus infection. Viruses 2011;3:1342-1357. 8 Sir D, Ann DK, Ou JH. Autophagy by hepatitis B virus and for hepatitis B virus. Autophagy 2010;6:4383-4388. 9 Coller KE, Berger KL, Heaton NS, Cooper JD, Yoon

Open access
Diagnostic Dilemmas in Hepatitis C Virus Infection for Hemodialysis Patients

References 1. Izopet J, Sandres-Sauné K, Kamar N, et al. Incidence of HCV infection in French hemodialysis units: a prospective study. J Med Virol 2005;77(1):70-6. 2. Hinrichsen H, Leimenstoll G, Stegen G, et al. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut 2002;51(3):429-33. 3. Jadoul M, Poignet JL, Geddes C, et al. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European Multicentre Study

Open access
Subcutaneous, Ganglion and Pulmonary Sarcoidosis in a Patient with Chronic Hepatitis C Virus Infection

.Wu, “Granulomatous liver diseases: A review”, Journal of the Formosan Medical Association, 2012, 111, 3-13. 5. Hilario Nunes, Diane Bouvry, Paul Soler and Dominique Valeyre, “Sarcoidosis”, Orphanet Journal of Rare Diseases, 2007, 2:46. 6. Bonnet F, Morlat P, Dubuc J si colab., “Sarcoidosis-associated hepatitis C virus infection”, Dig Dis Sci, 2002; 47: 794-796 7. Giovinale M1, Fonnesu C, Soriano A si colab., “ Atypical sarcoidosis: case reports and review of the literature:, Eur Rev Med Pharmacol Sci., 2009 Mar;13 Suppl 1:37-44. 8. Kveim-Test, Wikipedia

Open access
Direct acting anti-hepatitis C virus drugs: Clinical pharmacology and future direction

Introduction Globally, the chronic hepatitis C virus (HCV) is a leading cause of liver diseases such as liver cirrhosis and hepatocellular carcinoma. It affects approximately 180 million people worldwide; about 3% of the world population. [1] Three to four million persons are newly infected each year, with the predominant prevalence being infection with genotype 1, followed by genotypes 2 and 3. The other genotypes, 4, 5, and 6, have specific geographical distribution. The infection with HCV occurs as the result of percutaneous transmission via infectious

Open access
Study of the Hepatitis C Virus in the Republic of Macedonia

circulating antibodies to a major etiologic virus of human non- A, non-B hepatitis. Science. 1989; 244(4902): 362-364. 5. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001; 345(1): 41-52. 6. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989; 244(4902): 359-362. 7. Houghton M. Hepatitis C virus, In: Fields BN, Knipe DM, Howley PM, Chanock RH, Eds. Fields Virology, 3rd ed. Philadelphia

Open access
A single-step multiplex quantitative real time polymerase chain reaction assay for hepatitis C virus genotypes

Introduction Hepatitis C virus (HCV) infection is a serious global health problem infecting 3-4 million people each year.[ 1 ] HCV infection presents both as asymptomatic as well as symptomatic infection. A high proportion of patients infected with HCV develop chronic liver diseases that result in cirrhosis of liver and hepatocellular carcinoma (HCC) in later stage. HCV infection is an indication for liver transplant all over the world.[ 2 ] Patients with HCV usually show a poor response to antiviral therapy with a high relapse rate of HCV infection after

Open access
Monoclonal B cell lymphocytosis in patients with hepatitis C virus infection: prevalence, demographic and laboratory correlations

References 1. Turner NC, Dusheiko G and Jones A. Hepatitis C and B-cell lymphoma. Ann Oncol 2003;14:1341-1345 2. Zignego AL, Gianinni C, Ferri C. Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 2007;13(17):2467-2475. 3. Vlădăreanu A-M. Limfoamele în corelaţie cu virusurile limfotrope. Editura Amaltea 2007.Cap. Limfoamele maligne şi virusurile hepatitice. Pag. 63-93 4. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G et al

Open access
Factors Affecting Recurrence of Hepatitis C Virus in Adult Living Donor Liver Transplantation Among Egyptian Patients

References Frank C, Mohamed M, Strickland T, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W and Sallam I. The role of parental antischistosomal therapy in the spread of HCV in Egypt. Lancet. 2000;355(9207):887-9 1. Kamal SM. Improving outcomes in patients with hepatitis C virus genotype 4. Am J Gastroenterol. 2007;102(11):2582-8. Schmeding M, Neumann UP, Puhl G, Bahra M, Neuhaus R, Neuhaus P. Hepatitis C Recurrence and Fibrosis Progression Are Not

Open access
Molecular Pathogenesis of Liver Steatosis Induced by Hepatitis C Virus

References 1. Chang ML, Yeh HC, Tsou YK, Wang CJ, Cheng HY, Sung CM, et al. HCV core-induced nonobese hepatic steatosis is associated with hypoadiponectinemia and is ameliorated by adiponectin administration. Obesity (Silver Spring) 2012; doi: 10.1038/ oby.2012.45. 2. Sato S, Fukasawa M, Yamakawa Y, Natsume T, Suzuki T, Shoji I, et al. Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein. J Biochem 2006;139:921-930. 3. Congiu M, Ryan MC, Desmond PV. No

Open access